GUTS Fractyl Health Inc.

$GUTS everyone should thank for leading the guts community to the slaughter! He’s bashing $SLS which means that it will likely 10x

$GUTS I’m convinced that BIORICH is a paid account! He had unparalleled conviction on this stock which is down75% in 5 trading days as well bashing $SLS which is up 420% in the last year! He lead you all off a cliff! These are just facts. The scammer has me blocked so send this to him! BIOFRAUD! Good luck recovering your money to anyone who this conman, paid poster or total moron got to invest!

hey 👋 just trying to get your latest take on the $GUTS situation. I have been combing through your messages and it’s full of $SLS stuff. What’s the latest on your high conviction play?

$GUTS Worth addressing the elephant in the room, especially since the cancerous cult from the $SLS board likes to crap on me (and my picks) or anyone not drinking the $SLS Kool-Aid. It's also worth addressing the lying and accusations from those low lifes. I have NEVER purposely misled anyone. I've had strong conviction on the science, data and potential while under estimating the financial optionality of $GUTS. I've bought when I said I was going to buy. I held through the R/S. I held through data. I've taken my lumps, but I maintained my conviction and remained transparent. As for $GUTS, now, I've closed my position pending funding/listing resolution. I still believe in the science, opportunity and rollout, but right now the cost of capital is far too much. I believe $GUTS has found their target ablation length and will be DeNovo approved for it. Can they be attractive for a partnership/buyout? Absolutely. Am I holding for that to happen. Unfortunately not. Cheers!

$GUTS Can see data this week, possibly Friday AH with a Monday Call, paired with a Partnership or strategic investment announcement. Timing seems appropriate given $GUTS's previous milestones and data releases. Cheers!

$GUTS The Viking bought GUTS at 1.38. All ya Apes! If you have GUTS and NUTS come and buy this stock $AMC $GME $OPEN $TSLA

$GUTS Mr. CEO is back on X/Twitter, well, sort of. But he's kinda right. It's not just the weight maintenance numbers, it's the why behind it. Stop a GLP-1 and the weight comes back within weeks – stop it after Revita and it's different (proven already). If a big company bought this, the first study to fund: biopsies at 6–12 months comparing stem cells and nutrient transporters against sham patients. The working theory: years of overeating reprogramme the duodenal lining to absorb more and push the body towards storing. Only Revita wipes that layer, and it grows back in an actual post-diet state (the GLP-1 'diet' doesn't seem to provide that) – which holds until you flood it again. If that's proven, the GLP-1 comparison would matter a lot less: it's a reset vs. a suppressant. At best, you'd own an adjunct therapy no drug can offer (for the foreseeable future). Yeah, a bit of fantasy time here. But glad to see the CEO hasn't given up yet :)

$GUTS BIOFRAUD OWES YOU ALL AN APOLOGY! One month listening to this clown would turn your $1000 into $201!

$GUTS $SLS how come everyone is thumbs uppp ‘ing or commenting except for ? This was his number 1 conviction play and it’s justified to understand his latest strategy as he gabs about all other names. Maybe someone else on the board can direct me to his latest on guts? Tia

$GUTS Thanks for bring this up. For those low lifes from the $SLS board trolling and accusing me of leading people down a path, I think this response to BG in September puts that to rest. I don't play games. And for those that do, would you expect a 60% drop in Share Price following $GUTS hitting stat. sig. In their Primary endpoint? $SLS folks, this can happen to you. $GUTS Stat. Sig. on primary and dropped 60%.

$GUTS $GUTS Upcoming binary event worth the risk IMO. Topline 6-month randomized data for the REMAIN-1 Pivotal Cohort is due any day. With the market cap sitting heavily depressed, any definitive positive readout can easily launch SP 3x-6x. Past data points to a successful phase 3: • 84% vs 46%: Patients who received a complete Revita ablation maintained up to 84% of their GLP-1 weight loss at one year, compared to just 46% for the sham group. • 40% Overall Reduction: Even across the modified intent-to-treat (mITT) group, Revita reduced weight regain by roughly 40%. • Flawless Safety: Zero device-related serious adverse events. The Pivotal trail was prospectively designed and statistically powered based on these exact metrics de-risking upcoming data. Maximum negativity surrounding ticker belies a reversal and multi-bagger move near term with positive catalysts. Combine positive data with a non-dilutive partner announcement and a violent fomo SP rerate would ensue.

$GUTS has lost all credibility. In January, they led with “70% less weight regain” from an exploratory subgroup of just 20 patients, even though the study wasn’t powered to prove efficacy. That data release is now part of a lawsuit alleging Revita’s prospects were overstated. Then came months of commercialization hype. The reverse split was framed as something the board could do if needed—and now they’ve chosen 1-for-12 before delivering the pivotal results shareholders were waiting for. After this, why should anyone believe another word they say? We’ve been strung along, blindsided, and left holding the consequences.

$GUTS So let me get this straight… Now out of cash in April Will burn $8M per quarter FDA approval in “late 2027” So they need at least $20M in new cash Current market cap $15M So the market cap of the entire company won’t raise enough cash! And oh, they have $30M of debt accruing $4M per year in interest (not included in the $8M cash burn) And that’s IF everything goes right (12-month data is good and FDA approves). And after approval, more cash needed to commercialize and who the hell will pay $10K to keep an extra 6 lbs off? Would an insurer even reimburse? And Rejuva was a fake (obviously doesn’t work). This stock is going to zero.

$GUTS I wanted to believe in GUTS. The science looked good, and July’s results gave me hope. But at this point, pretending this is still on track feels ridiculous. The stock price is sending a clear message: investors don’t trust this company. The results haven’t shown enough to make commercialization believable, and shareholders are walking away. The CEO helped create this mess by trying to spin the site problems instead of being straight with investors. He’s burned through whatever credibility he had, and now he just sits there while the company sinks. The board needs to fire him. GUTS needs leadership investors can believe—not another excuse from the person who helped destroy their confidence.

$GUTS honestly had to stop looking at this thing. I never EVER hold through a reverse split but I was feeling optimistic here and rolled the dice. What a punch in the dick that was. Faces delisting. Reverse split takes place October 5, 2026. Share price back over $5. Fast forward to October 28, 2026 and we are under a buck facing delisting again HAHAHA. Where the heck did I put my lawyers phone number?

$GUTS If the macro picture brightens and the 12-month data comes in on par with the midpoint (which seems likely enough, since the two are running parallel so far), bankruptcy doesn’t look like the most plausible outcome. The CEO will grind this out. Or somebody will see the merit in it, as before – again, the data hasn’t changed. If macro stays the same and the >14 cm group somehow doesn’t deliver midpoint-like results, then yes, things might go south fast(er). I’d combine the two factors (good+good, good+bad, bad+good, bad+bad) and argue the combinations lead to different outcomes here. People really seem to overweight their read of the data – and underestimate how (NOT) keen capital is on microcaps right now.

$GUTS so has biodouche ghosted the GUTS board? Has he moved on to manipulative and deceive other boards? Sociopath.

$GUTS Well, I’ve been warning everyone since I sold at -$9/share the day of their commercial presentation in early September. Think about this…they’re now at a ~$15M market cap and this CEO pays himself $1M a year in cash (including a $610K base salary) plus was granted options this year with an accounting value of $5.4M. Just to pay him $1M next year represents ~6% of the company’s market cap! And they have ~$30M of debt accruing at 13.25% interest…$4M per year in interest expense (and it’s a floating rate)! They’ve said they’ll be out of cash by early next year. And even if they file for approval, the 12-month data won’t be ready to submit until early March. And even if they got approved, the market won’t care (it’s not commercial). The only miracle that can save them is Rejuva data and there is no timeline when that might come (a bad sign they’re so quiet about it). This is sub-$1 dollar soon…who knows what a cap raise even looks like (if it’s even possible). Sell now!

$GUTS im not so sure they would care if shareholders suffer , theyre looking for their own best interest , like anyone would , shareholders are jyst collateral damage on their way to make themselves whole

$GUTS Hoping for minimally dilutive financing tied to data or performance milestones. Also hoping that new financing doesn’t come in offering large post-money stock packages to management and the board. Would be terrible if they were personally made whole through the dilution and the rest of the shareholders suffered. I am overdosing on hopium at this point LOL